0001209191-23-036994.txt : 20230614 0001209191-23-036994.hdr.sgml : 20230614 20230614160026 ACCESSION NUMBER: 0001209191-23-036994 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230612 FILED AS OF DATE: 20230614 DATE AS OF CHANGE: 20230614 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kaufmann Gunnar F. CENTRAL INDEX KEY: 0001786754 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50549 FILM NUMBER: 231014054 MAIL ADDRESS: STREET 1: C/O ONCTERNAL THERAPEUTICS, INC. STREET 2: 12230 EL CAMINO REAL, SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Oncternal Therapeutics, Inc. CENTRAL INDEX KEY: 0001260990 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 621715807 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12230 EL CAMINO REAL STREET 2: SUITE 230 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: (858) 434-1113 MAIL ADDRESS: STREET 1: 12230 EL CAMINO REAL STREET 2: SUITE 230 CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: GTX INC /DE/ DATE OF NAME CHANGE: 20030822 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-06-12 0 0001260990 Oncternal Therapeutics, Inc. ONCT 0001786754 Kaufmann Gunnar F. 12230 EL CAMINO REAL, SUITE 230 SAN DIEGO CA 92130 0 1 0 0 Chief Scientific Officer 0 Common Stock 2023-06-12 4 P 0 25000 0.3498 A 91726 D Common Stock 2023-06-14 4 P 0 3000 0.3597 A 94726 D The reported price is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $0.3448 to $0.3500. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the SEC Staff, upon request, full information regarding the number of shares purchased at each price within the range set forth above. /s/Chase C. Leavitt, Attorney-in-fact 2023-06-14